MedTrace Logo

Intrathecal Morphine in Robot-assisted Prostatectomy

NCT01991275 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2015-07-03

No results posted yet for this study

Summary

This study will investigate the efficacy and safety of intrathecal morphine for the patients undergoing robot-assisted prostatectomy

Conditions

  • Prostatic Neoplasms

Interventions

DRUG

The intravenous patient-controlled analgesia

The intravenous injection of morphine using the patient-controlled analgesia machine

DRUG

The intrathecal morphine injection

A single injection of morphine intrathecally

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Deok-Man Hong, PhD · Seoul National University of Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2014-06-30
Completion
2014-06-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01991275 on ClinicalTrials.gov